Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Which Primary Organ Is Most Suitable for Performing Pulmonary Metastasectomy?

Hirai F, Kinoshita I, Matsubara T, Haratake N, Kouzuma Y, Takamori S, Akamine T, Toyokawa G, Tagawa T, Takenoyama M, Maehara Y.

Anticancer Res. 2018 Feb;38(2):1041-1045.

PMID:
29374738
2.

SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.

Kohashi K, Yamamoto H, Yamada Y, Kinoshita I, Taguchi T, Iwamoto Y, Oda Y.

Am J Surg Pathol. 2018 Mar;42(3):312-318. doi: 10.1097/PAS.0000000000001011.

PMID:
29309303
3.

A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002).

Ikezawa Y, Asahina H, Oizumi S, Watanabe M, Takamura K, Kawai Y, Yamada N, Harada T, Kinoshita I, Fujita Y, Miyauchi E, Ogi T, Amano T, Furuta M, Sakakibara-Konishi J, Nishihara H, Dosaka-Akita H, Isobe H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group.

Cancer Chemother Pharmacol. 2017 Nov;80(5):955-963. doi: 10.1007/s00280-017-3432-4. Epub 2017 Sep 13.

PMID:
28905108
4.

Junctional Rhythm Preoperatively and During General Anesthesia for Oral and Maxillofacial Surgery.

Kishimoto N, Kinoshita I, Momota Y.

Anesth Prog. Fall 2017;64(3):165-167. doi: 10.2344/anpr-64-03-08.

PMID:
28858547
5.

Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.

Yamada Y, Kinoshita I, Kenichi K, Yamamoto H, Iwasaki T, Otsuka H, Yoshimoto M, Ishihara S, Toda Y, Kuma Y, Setsu N, Koga Y, Honda Y, Inoue T, Yanai H, Yamashita K, Ito I, Takahashi M, Ohga S, Furue M, Nakashima Y, Oda Y.

Histopathology. 2018 Feb;72(3):460-471. doi: 10.1111/his.13377. Epub 2017 Nov 16.

PMID:
28858396
6.

Autophagy-dependent regulation of tumor metastasis by myeloid cells.

Jinushi M, Morita T, Xu Z, Kinoshita I, Dosaka-Akita H, Yagita H, Kawakami Y.

PLoS One. 2017 Jul 7;12(7):e0179357. doi: 10.1371/journal.pone.0179357. eCollection 2017.

7.

HIF-1α, MDM2, CDK4, and p16 expression in ischemic fasciitis, focusing on its ischemic condition.

Yamada Y, Kinoshita I, Kohashi K, Yamamoto H, Kuma Y, Ito T, Koda K, Kisanuki A, Kurosawa M, Yoshimura M, Furue M, Oda Y.

Virchows Arch. 2017 Jul;471(1):117-122. doi: 10.1007/s00428-017-2122-2. Epub 2017 May 6.

PMID:
28477272
8.

Thymoma-associated multi-organ autoimmunity: two cases and a review of the literature.

Shiba K, Fujita Y, Miyazawa H, Muramatsu K, Watanabe M, Nishimura M, Shinkuma S, Nomura T, Nishie W, Taguchi J, Kinoshita I, Shimizu H.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):e324-e326. doi: 10.1111/jdv.14108. Epub 2017 Jan 23. No abstract available.

PMID:
28052464
9.

Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.

Sakakibara-Konishi J, Ikezawa Y, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M.

Int J Clin Oncol. 2017 Apr;22(2):257-268. doi: 10.1007/s10147-016-1060-3. Epub 2016 Nov 5.

PMID:
27816990
10.

Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Saito Y, Kobayashi M, Yamada T, Kasashi K, Honma R, Takeuchi S, Shimizu Y, Kinoshita I, Dosaka-Akita H, Iseki K.

Support Care Cancer. 2017 Feb;25(2):481-487. doi: 10.1007/s00520-016-3426-5. Epub 2016 Oct 3.

PMID:
27699503
11.

Role of targeted therapy in metastatic colorectal cancer.

Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H.

World J Gastrointest Oncol. 2016 Sep 15;8(9):642-55. doi: 10.4251/wjgo.v8.i9.642. Review.

12.

A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.

Usui K, Sugawara S, Nishitsuji M, Fujita Y, Inoue A, Mouri A, Watanabe H, Sakai H, Kinoshita I, Ohhara Y, Maemondo M, Kagamu H, Hagiwara K, Kobayashi K; North East Japan Study Group.

Lung Cancer. 2016 Sep;99:131-6. doi: 10.1016/j.lungcan.2016.07.003. Epub 2016 Jul 5.

PMID:
27565928
13.

Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.

Takashina T, Kinoshita I, Kikuchi J, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Nishimura M, Dosaka-Akita H.

Cancer Sci. 2016 Jul;107(7):955-62. doi: 10.1111/cas.12957. Epub 2016 Jun 13.

14.

Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer.

Elmansuri AZ, Tanino MA, Mahabir R, Wang L, Kimura T, Nishihara H, Kinoshita I, Dosaka-Akita H, Tsuda M, Tanaka S.

Oncotarget. 2016 May 10;7(19):27094-107. doi: 10.18632/oncotarget.8314.

15.

Randomized phase II trial comparing amrubicin with re-challenge of platinum doublet in patients with sensitive-relapsed small-cell lung cancer: North Japan Lung Cancer Study Group trial 0702.

Inoue A, Sugawara S, Maemondo M, Mori Y, Oizumi S, Harada M, Taima K, Morikawa N, Ishida T, Kinoshita I, Watanabe H, Suzuki T, Nakagawa T, Saito R, Nukiwa T.

Lung Cancer. 2015 Jul;89(1):61-5. doi: 10.1016/j.lungcan.2015.04.012. Epub 2015 May 4.

PMID:
26004087
16.

The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.

Komohara Y, Morita T, Annan DA, Horlad H, Ohnishi K, Yamada S, Nakayama T, Kitada S, Suzu S, Kinoshita I, Dosaka-Akita H, Akashi K, Takeya M, Jinushi M.

Cancer Immunol Res. 2015 Sep;3(9):999-1007. doi: 10.1158/2326-6066.CIR-14-0156. Epub 2015 Mar 17.

17.

Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutation.

Fukuhara T, Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Saijo Y, Hagiwara K, Morita S, Nukiwa T.

Lung Cancer. 2015 May;88(2):181-6. doi: 10.1016/j.lungcan.2015.02.004. Epub 2015 Feb 9.

18.

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.

Sugawara S, Oizumi S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Yoshizawa H, Ito K, Gemma A, Nishitsuji M, Harada M, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Kurihara M, Nukiwa T; North East Japan Study Group and Tokyo Cooperative Oncology Group.

Ann Oncol. 2015 May;26(5):888-94. doi: 10.1093/annonc/mdv063. Epub 2015 Feb 10.

PMID:
25669832
19.
20.

Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.

Honma R, Kinoshita I, Miyoshi E, Tomaru U, Matsuno Y, Shimizu Y, Takeuchi S, Kobayashi Y, Kaga K, Taniguchi N, Dosaka-Akita H.

Oncology. 2015;88(5):298-308. doi: 10.1159/000369495. Epub 2015 Jan 7.

PMID:
25572677
21.

Chelated bis-N-heterocyclic carbene platinum and palladium units as tunable components of multinuclear complexes.

Maeda Y, Hashimoto H, Kinoshita I, Nishioka T.

Inorg Chem. 2015 Jan 20;54(2):448-59. doi: 10.1021/ic502039d. Epub 2015 Jan 7.

PMID:
25563064
22.

Children's Play Environment after a Disaster: The Great East Japan Earthquake.

Kinoshita I, Woolley H.

Children (Basel). 2015 Jan 28;2(1):39-62. doi: 10.3390/children2010039.

23.

[A case of an anti-SRP myopathy with enlargement of the thymus].

Ohta R, Mukaino A, Kinoshita I, Tsujihata M, Suzuki S.

Rinsho Shinkeigaku. 2014;54(10):798-802. Japanese.

PMID:
25342013
24.

Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.

Kanazawa K, Yokouchi H, Wang X, Ishida T, Fujita Y, Fujiuchi S, Harada T, Harada M, Takamura K, Oizumi S, Kinoshita I, Katsuura Y, Honjo O, Kojima T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M; Hokkaido Lung Cancer Clinical Study Group.

Cancer Chemother Pharmacol. 2014 Dec;74(6):1149-57. doi: 10.1007/s00280-014-2589-3. Epub 2014 Oct 8.

PMID:
25294632
25.

μ2-Acetato-κ(2) O:O'-(4,4'-bipyridyl-κN)tris-(diethyl di-thio-phosphato-κ(2) S,S')-μ3-sulfido-tri-μ2-sulfido-trimolybdenum(IV) diethyl ether monosolvate.

Kawamoto K, Kinoshita I.

Acta Crystallogr Sect E Struct Rep Online. 2014 Jun 4;70(Pt 7):m240-1. doi: 10.1107/S1600536814012501. eCollection 2014 Jul 1.

26.

Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4.

Jinushi T, Shibayama Y, Kinoshita I, Oizumi S, Jinushi M, Aota T, Takahashi T, Horita S, Dosaka-Akita H, Iseki K.

Cancer Med. 2014 Dec;3(6):1544-52. doi: 10.1002/cam4.309. Epub 2014 Aug 1.

27.

Synthesis, magnetic properties and dynamic behavior of cobalt complexes with an anthracene-containing dioxolene ligand.

Katayama K, Hirotsu M, Kinoshita I, Teki Y.

Dalton Trans. 2014 Sep 21;43(35):13384-91. doi: 10.1039/c4dt01574f.

PMID:
25075775
28.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.

Mizumachi T, Homma A, Kakizaki T, Sakashita T, Kano S, Hatakeyama H, Tsuchiya K, Yasuda K, Onimaru R, Shirato H, Taguchi J, Shimizu Y, Kinoshita I, Akita H, Fukuda S.

Int J Clin Oncol. 2015 Jun;20(3):431-7. doi: 10.1007/s10147-014-0726-y. Epub 2014 Jul 5.

PMID:
24993675
29.

[Case of herpes simplex encephalitis with hypersomnia and low orexin level in the cerebrospinal fluid].

Mukaino A, Kinoshita I, Fukushima N, Otsubo M, Kanbayashi T.

Rinsho Shinkeigaku. 2014;54(3):207-11. Japanese.

PMID:
24705834
30.

Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease.

Nakamura T, Satoh K, Fukuda T, Kinoshita I, Nishiura Y, Nagasato K, Yamauchi A, Kataoka Y, Nakamura T, Sasaki H, Kumagai K, Niwa M, Noguchi M, Nakamura H, Nishida N, Kawakami A.

J Neurovirol. 2014 Jun;20(3):269-77. doi: 10.1007/s13365-014-0244-8. Epub 2014 Mar 27.

PMID:
24671717
31.

Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells.

Yamashina T, Baghdadi M, Yoneda A, Kinoshita I, Suzu S, Dosaka-Akita H, Jinushi M.

Cancer Res. 2014 May 15;74(10):2698-709. doi: 10.1158/0008-5472.CAN-13-2169. Epub 2014 Mar 17.

32.

HPV-associated lung cancers: an international pooled analysis.

Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, Spandidos DA, Gorgoulis V, Heideman DA, van Boerdonk RA, Hiroshima K, Iwakawa R, Kastrinakis NG, Kinoshita I, Akiba S, Landi MT, Eugene Liu H, Wang JL, Mehra R, Khuri FR, Lim WT, Owonikoko TK, Ramalingam S, Sarchianaki E, Syrjanen K, Tsao MS, Sykes J, Hee SW, Yokota J, Zaravinos A, Taioli E.

Carcinogenesis. 2014 Jun;35(6):1267-75. doi: 10.1093/carcin/bgu038. Epub 2014 Feb 12.

33.
34.

TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.

Baghdadi M, Yoneda A, Yamashina T, Nagao H, Komohara Y, Nagai S, Akiba H, Foretz M, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Takeya M, Viollet B, Yagita H, Jinushi M.

Immunity. 2013 Dec 12;39(6):1070-81. doi: 10.1016/j.immuni.2013.09.014. Epub 2013 Dec 5.

35.

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial.

Nakamura T, Matsuo T, Fukuda T, Yamato S, Yamaguchi K, Kinoshita I, Matsuzaki T, Nishiura Y, Nagasato K, Narita-Masuda T, Nakamura H, Satoh K, Sasaki H, Sakai H, Kawakami A.

BMC Med. 2013 Aug 15;11:182. doi: 10.1186/1741-7015-11-182.

36.

Titanium and manganese complexes supported by a xanthene-bridged bis(tripodal N2O2) ligand: isomerization, intramolecular hydrogen bonding and metal-binding ability.

Hirotsu M, Kawamoto K, Tanaka R, Nagai Y, Ueno K, Teki Y, Kinoshita I.

Dalton Trans. 2013 Sep 14;42(34):12220-7. doi: 10.1039/c3dt51389k. Epub 2013 Jul 10.

PMID:
23842790
37.

[A case of meningeal disseminated sarcoidosis with marked hypoglycorrhachia in the CSF].

Mukaino A, Kinoshita I, Asai M, Toriyama F, Nakata R, Motomura M, Matsuo T, Hayashi T.

Rinsho Shinkeigaku. 2013;53(5):367-71. Japanese.

PMID:
23719985
38.

CD133 expression: a potential prognostic marker for non-small cell lung cancers.

Mizugaki H, Sakakibara-Konishi J, Kikuchi J, Moriya J, Hatanaka KC, Kikuchi E, Kinoshita I, Oizumi S, Dosaka-Akita H, Matsuno Y, Nishimura M.

Int J Clin Oncol. 2014 Apr;19(2):254-9. doi: 10.1007/s10147-013-0541-x. Epub 2013 Mar 12.

PMID:
23479121
39.

A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.

Harada T, Oizumi S, Ito K, Takamura K, Kikuchi E, Kuda T, Sugawara S, Suzuki A, Maemondo M, Fujita Y, Kinoshita I, Inoue A, Hommura F, Katsuura Y, Dosaka-Akita H, Isobe H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group.

Oncologist. 2013;18(4):439-45. doi: 10.1634/theoncologist.2012-0308. Epub 2013 Feb 26.

40.
41.

Syntheses, characterization, and antitumor activities of platinum(II) and palladium(II) complexes with sugar-conjugated triazole ligands.

Yano S, Ohi H, Ashizaki M, Obata M, Mikata Y, Tanaka R, Nishioka T, Kinoshita I, Sugai Y, Okura I, Ogura S, Czaplewska JA, Gottschaldt M, Schubert US, Funabiki T, Morimoto K, Nakai M.

Chem Biodivers. 2012 Sep;9(9):1903-15. doi: 10.1002/cbdv.201100426.

PMID:
22976979
42.

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002).

Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group.

Ann Oncol. 2013 Jan;24(1):54-9. doi: 10.1093/annonc/mds214. Epub 2012 Sep 11.

PMID:
22967997
43.

Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.

Kikuchi J, Takashina T, Kinoshita I, Kikuchi E, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Marquez VE, Nishimura M, Dosaka-Akita H.

Lung Cancer. 2012 Nov;78(2):138-43. doi: 10.1016/j.lungcan.2012.08.003. Epub 2012 Aug 25.

44.

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.

Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M.

Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29.

45.

Expression of Bim, Noxa, and Puma in non-small cell lung cancer.

Sakakibara-Konishi J, Oizumi S, Kikuchi J, Kikuchi E, Mizugaki H, Kinoshita I, Dosaka-Akita H, Nishimura M.

BMC Cancer. 2012 Jul 12;12:286. doi: 10.1186/1471-2407-12-286.

46.

Masked function of amino acid sensors on pancreatic hormone secretion in ventromedial hypothalamic (VMH) lesioned rats with marked hyperinsulinemia.

Ishizuka N, Tanaka K, Suzuki Y, Kintaka Y, Kinoshita I, Hashiguchi T, Shimizu H, Senoo A, Imazeki N, Kobayashi Y, Arai K, Haba R, Takahashi T, Sasaki K, Kako M, Hayashi K, Osaka T, Suzuki Y, Inoue S.

Obes Res Clin Pract. 2012 Jul-Sep;6(3):e175-262. doi: 10.1016/j.orcp.2011.11.008.

PMID:
24331525
47.

Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

Oizumi S, Kobayashi K, Inoue A, Maemondo M, Sugawara S, Yoshizawa H, Isobe H, Harada M, Kinoshita I, Okinaga S, Kato T, Harada T, Gemma A, Saijo Y, Yokomizo Y, Morita S, Hagiwara K, Nukiwa T.

Oncologist. 2012;17(6):863-70. doi: 10.1634/theoncologist.2011-0426. Epub 2012 May 11.

48.

Bis(μ(2)-4,7-dimethyl-4,7-diazadecane-1,10-dithiolato)trinickel(II) bis(perchlorate).

Hirotsu M, Kuwamura N, Kinoshita I, Kojima M, Yoshikawa Y.

Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):m307. doi: 10.1107/S1600536812006034. Epub 2012 Feb 17.

49.

Anion-controlled assembly of four manganese ions: structural, magnetic, and electrochemical properties of tetramanganese complexes stabilized by xanthene-bridged Schiff base ligands.

Hirotsu M, Shimizu Y, Kuwamura N, Tanaka R, Kinoshita I, Takada R, Teki Y, Hashimoto H.

Inorg Chem. 2012 Jan 16;51(2):766-8. doi: 10.1021/ic202287k. Epub 2011 Dec 22.

PMID:
22191477
50.

[A case of non-alcoholic fatty liver disease (NAFLD) aggravated after treatment with raloxifene].

Matsumura M, Tashiro K, Miura A, Tajima T, Kinoshita I, Kojima E, Yoshizawa A.

Nihon Shokakibyo Gakkai Zasshi. 2011 Dec;108(12):2036-41. Japanese.

PMID:
22139492

Supplemental Content

Loading ...
Support Center